SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-123728
Filing Date
2023-12-06
Accepted
2023-12-05 20:51:53
Documents
18
Period of Report
2023-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FROM 8-K tm2332198d1_8k.htm   iXBRL 8-K 35851
2 EXHIBIT 4.1 tm2332198d1_ex4-1.htm EX-4.1 305759
3 EXHIBIT 10.1 tm2332198d1_ex10-1.htm EX-10.1 57959
4 EXHIBIT 99.1 tm2332198d1_ex99-1.htm EX-99.1 21975
8 GRAPHIC tm2332198d1_ex4-1img001.jpg GRAPHIC 1854
9 GRAPHIC tm2332198d1_ex4-1img002.jpg GRAPHIC 2629
10 GRAPHIC tm2332198d1_ex99-1img001.jpg GRAPHIC 6572
  Complete submission text file 0001104659-23-123728.txt   696035

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fencf-20231204.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20231204_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20231204_pre.xml EX-101.PRE 22358
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2332198d1_8k_htm.xml XML 3327
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 231468254
SIC: 2836 Biological Products, (No Diagnostic Substances)